Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of SCT650C in rheumatoid arthritis
CTR20250516Phase 2Active
- Sponsor
- Sinocelltech Group Limited
- Start
- Feb 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of SCT650C in rheumatoid arthritis (RA), sponsored by Sinocelltech Group Limited. Started Feb 2025; status: active.
02
Drugs
SCT650C
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20250516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250516.